Item 7.01 Regulation FD Disclosure.



On January 5, 2022, Immunovant, Inc. will hold a pre-announced webcast and
provide investors with a business update. A copy of the presentation to be used
during the webcast is attached hereto as Exhibit 99.1 and is incorporated herein
by reference.

The information furnished under this Item 7.01, including Exhibit 99.1, shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or subject to the liabilities of that section or Sections
11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall
not be deemed incorporated by reference into any other filing with the
Securities and Exchange Commission made by Immunovant, regardless of any general
incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
Exhibit No.                  Description
99.1                           Presentation, dated January 5, 2022.
104                          Cover Page Interactive Data File (embedded

within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses